The ARC Hemovigilance Program: Advancing the safety of blood donation and transfusion

Immunohematology

Volumn 25, Issue 4, 2009, Pages 179-185

  Eder, Anne F ^a   Dy, Beth A ^a   Barton, Jessica ^a   Kennedy, Jean M ^a   Benjamin, Richard J ^a  

^a AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BABESIOSIS; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; HEALTH PROGRAM; HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; RED CROSS; SEPSIS; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE LUNG INJURY; APHERESIS; BLOOD; BLOOD COMPONENT THERAPY; COMMUNICABLE DISEASE; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; ERYTHROCYTE; GOVERNMENT REGULATION; HEALTH CARE QUALITY; MICROBIOLOGY; MORTALITY; PARASITOLOGY; PATHOLOGY; PRACTICE GUIDELINE; SURVIVAL; THROMBOCYTE; VIROLOGY;

ACUTE LUNG INJURY; BABESIOSIS; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; BLOOD PLATELETS; COMMUNICABLE DISEASES; ERYTHROCYTES; GOVERNMENT REGULATION; MOLECULAR DIAGNOSTIC TECHNIQUES; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; RED CROSS; SURVIVAL ANALYSIS;

EID: 77951780330     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007;47:1134-1142
2. Eder AF, Kennedy JM, Dy BA, et al. Limiting and detecting bacterial contamination of apheresis platelets: inletline diversion and increased culture volume improve component safety. Transfusion 2009; 49:1554-1563
3. Eder AF, Herron R, Strupp A, et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007;47:599-607.
4. Eder AF, Dy BA, Herron RM, Strupp A, Dodd RY, Benjamin RJ. Effective reduction of TRALI risk with plasma collected predominantly from male donors. Transfusion 2009; 49(Suppl):45A.
5. Tonnetti L, Eder AF, Dy BA, et al. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009; 49:2557-2563
6. Eder AF, Dy BA, Kennedy J, et al. The American Red Cross Donor Hemovigilance Program: complications of blood donation reported in 2006. Transfusion 2008;48:1809-1819
7. Benjamin RJ, Dy BA, Kennedy JM, Notari EP, Eder AF. The relative safety of automated two-unit red blood cell procedures and manual whole-blood collection in young donors. Transfusion 2009; 49:1874-1883
8. Eder AF, Hillyer CD, Dy BA, Notari EP, Benjamin RJ. Adverse reactions to allogeneic whole blood donation by 16- and 17-year-olds. JAMA 2008;299:2279-2286
9. Eder AF, Dy BA, Ralston J, et al. Effective reduction of donor reactions on high school drives with standard work guidance. Transfusion 2009;49(Suppl):51A.
10. Code of Federal Regulations Title 21 CFR 606.170(a) and (b), 2009 Washington, DC. US Government Printing Office.
11. FDA/Centers for Biologics Evaluation and Research. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2008. Available at http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ ReportaProblem/TransfusionDonationFatalities/ucm113649.htm. Accessed August 12, 2009.
12. Taylor C, Cohen H, Mold D, et al., on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2008 Annual SHOT Report (2009). www.shotuk.org.
13. Fang CT, Chambers LA, Kennedy J, et al. Detection of bacterial contamination in apheresis products: American Red Cross experience, 2004. Transfusion 2005;45:1845-1852
14. Wagner SJ, Eder AF. A model to predict the improvement of automated blood culture bacterial detection by doubling platelet sample volume. Transfusion 2007;47:430-433 (Pubitemid 46272489)
15. Benjamin RJ, Kline L, Dy BA, et al. Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008;48:2348-2355
16. Stramer SL. Current risks of transfusion-transmitted agents. Arch Pathol Lab Med 2007;131:702-707
17. Code of Federal Regulations 21 CFR 610.46 Human immunodeficiency virus (HIV) "lookback" requirements; 21 CFR 610.47, Hepatitis C virus (HCV) "lookback" requirements; 2009 Washington, DC. US Government Printing Office. Available at http://frwebgate2.access.gpo.gov/cgi-bin/PDFgate.cgi? WAISdocID=s9imto/3/2/o&WAISaction=retrieve. Accessed August 12, 2009.
18. AABB Association Bulletin 09-06. Transfusion-transmitted Babesia. Bethesda, AABB.
19. The US Biovigilance Network. Available at http://www.aabb.org/Content/ Programs-and-Services/Data-Center/US-Biovigilance-Network. Accessed December 6, 2009.